Cargando…
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
[Image: see text] Undesirable side effects associated with orthosteric agonists/antagonists of cannabinoid 1 receptor (CB1R), a tractable target for treating several pathologies affecting humans, have greatly limited their translational potential. Recent discovery of CB1R negative allosteric modulat...
Autores principales: | Kulkarni, Pushkar M., Kulkarni, Abhijit R., Korde, Anisha, Tichkule, Ritesh B., Laprairie, Robert B., Denovan-Wright, Eileen M., Zhou, Han, Janero, David R., Zvonok, Nikolai, Makriyannis, Alexandros, Cascio, Maria G., Pertwee, Roger G., Thakur, Ganesh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716578/ https://www.ncbi.nlm.nih.gov/pubmed/26529344 http://dx.doi.org/10.1021/acs.jmedchem.5b01303 |
Ejemplares similares
-
Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
por: Laprairie, Robert B., et al.
Publicado: (2019) -
Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor
por: Mallipeddi, Srikrishnan, et al.
Publicado: (2018) -
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
por: Fichna, Jakub, et al.
Publicado: (2014) -
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
por: Brandt, Asher L., et al.
Publicado: (2022) -
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
por: Thapa, Dinesh, et al.
Publicado: (2020)